258 related articles for article (PubMed ID: 36430597)
1. Cytogenetics in Fanconi Anemia: The Importance of Follow-Up and the Search for New Biomarkers of Genomic Instability.
Merfort LW; Lisboa MO; Cavalli LR; Bonfim CMS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430597
[TBL] [Abstract][Full Text] [Related]
2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
3. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.
Tönnies H; Huber S; Kuhl JS; Gerlach A; Ebell W; Neitzel H
Blood; 2003 May; 101(10):3872-4. PubMed ID: 12511406
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
5. An uncommon t(9;11)(p24;q22) with monoallelic loss of
Lovatel VL; de Souza DC; Alvarenga TF; Capela de Matos RR; Diniz C; Schramm MT; Llerena Júnior JC; Silva MLM; Abdelhay E; de Souza Fernandez T
Mol Cytogenet; 2018; 11():40. PubMed ID: 30008805
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
[TBL] [Abstract][Full Text] [Related]
7. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
Vundinti BR; Korgaonkar S; Ghosh K
Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
[TBL] [Abstract][Full Text] [Related]
8. Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
Borges ML; Capela de Matos RR; Amaral BD; Soares-Ventura EM; Leite EP; Silva MO; Cornélio MT; Silva ML; Liehr T; Marques-Salles TD
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e85-e91. PubMed ID: 28212262
[TBL] [Abstract][Full Text] [Related]
9. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
10. Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.
Rochowski A; Olson SB; Alonzo TA; Gerbing RB; Lange BJ; Alter BP
Pediatr Blood Cancer; 2012 Nov; 59(5):922-4. PubMed ID: 22517793
[TBL] [Abstract][Full Text] [Related]
11. Chromosome abnormalities in bone marrow of Fanconi anemia patients.
Berger R; Le Coniat M; Schaison G
Cancer Genet Cytogenet; 1993 Jan; 65(1):47-50. PubMed ID: 8431915
[TBL] [Abstract][Full Text] [Related]
12. Two different karyotypes with 1q abnormalities in a patient with Fanconi anemia.
Oliveira NI; Ribeiro EM; Raimondi SC; Bittencourt MA; Pasquini R; Cavalli IJ
Leuk Res; 2002 Nov; 26(11):1047-9. PubMed ID: 12363475
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
14. [Fanconi anemia: cytogenetic diagnosis of 40 cases].
Porto B; Sousa R; Ponte F; Torgal A; Campilho F; Campos A; Gonçalves C; Barbot J
Acta Med Port; 2011; 24(3):405-12. PubMed ID: 22015027
[TBL] [Abstract][Full Text] [Related]
15. Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia.
Chang L; Zhang L; Zhao B; Cheng X; Wan Y; Zhang R; Yuan W; Gao X; Zhu X
BMC Med Genomics; 2023 Nov; 16(1):290. PubMed ID: 37974167
[TBL] [Abstract][Full Text] [Related]
16. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.
Auerbach AD; Allen RG
Cancer Genet Cytogenet; 1991 Jan; 51(1):1-12. PubMed ID: 1984836
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetics study of chromosomal instability in Fanconi anemia in Tunisia].
Chbili C; Bouraoui S; El Ghezal H; Saad A
Ann Biol Clin (Paris); 2014; 72(4):473-8. PubMed ID: 25119806
[TBL] [Abstract][Full Text] [Related]
18. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
Savage SA; Walsh MF
Hematol Oncol Clin North Am; 2018 Aug; 32(4):657-668. PubMed ID: 30047418
[TBL] [Abstract][Full Text] [Related]
20. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H
Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]